TheraSphere® At Your Fingertips
Designed for healthcare professionals, the App provides detailed information about TheraSphere®, an yttrium-90 glass microsphere therapy for hepatocellular carcinoma (HCC), including patients with or without partial or branch portal vein thrombosis (PVT).
iPad is a trademark of Apple Inc. All rights reserved.
Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc.
The TheraSphere® Preceptor Program connects physicians with experienced interventional radiologists that provide medical and technical advice to treatment users.